PURPOSE: To validate a prospectively triggered spiral phase-contrast magnetic resonance (MR) sequence accelerated with sensitivity encoding (SENSE) in a population of children and adults with congenital heart disease. MATERIALS AND METHODS: The local research ethics committee approved this study, and written consent was obtained from all patients or guardians. Stroke volumes were quantified in 40 patients (mean age ± standard deviation: 21.4 years ± 13.8, age range: 3.0-61.3 years; 22 male patients aged 3.0-38.0 years [mean age, 17.2 years ± 10.5], 18 female patients aged 4.7-61.3 years [mean age, 26.6 years ± 15.9]) with congenital heart disease in the aorta (n = 40), main pulmonary artery (n = 38), right pulmonary artery (n = 22), and left pulmonary artery (n = 24). Stroke volumes were obtained with (a) breath-hold spiral phase-contrast MR imaging with SENSE, (b) conventional breath-hold cartesian phase-contrast MR imaging, and (c) reference free-breathing phase-contrast MR imaging. Stroke volumes were compared by using repeated-measures analysis of variance, Bland-Altman analysis, and correlation coefficients. RESULTS: Imaging time with the breath-hold spiral phase-contrast MR sequence was significantly lower than that with the conventional breath-hold phase-contrast MR sequence (~5 seconds vs ~16 seconds, respectively; P < .0001). There was excellent agreement in stroke volumes in all vessels between the reference free-breathing sequence (mean volume, 60.3 mL ± 27.3) and the two breath-hold sequences-spiral SENSE phase-contrast MR imaging (mean volume, 59.5 mL ± 27.1; P < .001) and conventional cartesian phase-contrast MR imaging (mean volume, 59.8 mL ± 27.6; P = .268). The limits of agreement were smaller with the spiral breath-hold sequence than with the conventional breath-hold sequence (-4.4 mL, 2.9 mL vs -10.3 mL, 9.3 mL, respectively); correlation was similar (r = 0.998 vs r = 0.984, respectively). CONCLUSION: Flow volumes can be accurately and reliably quantified by using a spiral SENSE phase-contrast MR sequence, with high spatiotemporal resolution obtained in a short breath hold.
PURPOSE: To validate a prospectively triggered spiral phase-contrast magnetic resonance (MR) sequence accelerated with sensitivity encoding (SENSE) in a population of children and adults with congenital heart disease. MATERIALS AND METHODS: The local research ethics committee approved this study, and written consent was obtained from all patients or guardians. Stroke volumes were quantified in 40 patients (mean age ± standard deviation: 21.4 years ± 13.8, age range: 3.0-61.3 years; 22 male patients aged 3.0-38.0 years [mean age, 17.2 years ± 10.5], 18 female patients aged 4.7-61.3 years [mean age, 26.6 years ± 15.9]) with congenital heart disease in the aorta (n = 40), main pulmonary artery (n = 38), right pulmonary artery (n = 22), and left pulmonary artery (n = 24). Stroke volumes were obtained with (a) breath-hold spiral phase-contrast MR imaging with SENSE, (b) conventional breath-hold cartesian phase-contrast MR imaging, and (c) reference free-breathing phase-contrast MR imaging. Stroke volumes were compared by using repeated-measures analysis of variance, Bland-Altman analysis, and correlation coefficients. RESULTS: Imaging time with the breath-hold spiral phase-contrast MR sequence was significantly lower than that with the conventional breath-hold phase-contrast MR sequence (~5 seconds vs ~16 seconds, respectively; P < .0001). There was excellent agreement in stroke volumes in all vessels between the reference free-breathing sequence (mean volume, 60.3 mL ± 27.3) and the two breath-hold sequences-spiral SENSE phase-contrast MR imaging (mean volume, 59.5 mL ± 27.1; P < .001) and conventional cartesian phase-contrast MR imaging (mean volume, 59.8 mL ± 27.6; P = .268). The limits of agreement were smaller with the spiral breath-hold sequence than with the conventional breath-hold sequence (-4.4 mL, 2.9 mL vs -10.3 mL, 9.3 mL, respectively); correlation was similar (r = 0.998 vs r = 0.984, respectively). CONCLUSION: Flow volumes can be accurately and reliably quantified by using a spiral SENSE phase-contrast MR sequence, with high spatiotemporal resolution obtained in a short breath hold.
Authors: Olaf Dietrich; José G Raya; Scott B Reeder; Maximilian F Reiser; Stefan O Schoenberg Journal: J Magn Reson Imaging Date: 2007-08 Impact factor: 4.813
Authors: A J Evans; F Iwai; T A Grist; H D Sostman; L W Hedlund; C E Spritzer; R Negro-Vilar; C A Beam; N J Pelc Journal: Invest Radiol Date: 1993-02 Impact factor: 6.016
Authors: D N Firmin; G L Nayler; R H Klipstein; S R Underwood; R S Rees; D B Longmore Journal: J Comput Assist Tomogr Date: 1987 Sep-Oct Impact factor: 1.826
Authors: Gert Klug; Sebastian Johannes Reinstadler; Hans-Josef Feistritzer; Christian Kremser; Johannes P Schwaiger; Martin Reindl; Johannes Mair; Silvana Müller; Agnes Mayr; Wolfgang-Michael Franz; Bernhard Metzler Journal: Eur Radiol Date: 2015-09-18 Impact factor: 5.315
Authors: Albert Hsiao; Umar Tariq; Marcus T Alley; Michael Lustig; Shreyas S Vasanawala Journal: J Magn Reson Imaging Date: 2014-02-08 Impact factor: 4.813
Authors: Jakob A Hauser; Alexander Jones; Bejal Pandya; Andrew M Taylor; Vivek Muthurangu Journal: Am J Physiol Heart Circ Physiol Date: 2020-08-28 Impact factor: 4.733
Authors: Karl Fengler; Karl-Philipp Rommel; Stephan Blazek; Maximilian Von Roeder; Christian Besler; Christian Lücke; Matthias Gutberlet; Jennifer Steeden; Michael Quail; Steffen Desch; Holger Thiele; Vivek Muthurangu; Philipp Lurz Journal: Clin Res Cardiol Date: 2018-05-09 Impact factor: 5.460
Authors: Giovanni Biglino; Jennifer A Steeden; Catriona Baker; Silvia Schievano; Andrew M Taylor; Kim H Parker; Vivek Muthurangu Journal: J Cardiovasc Magn Reson Date: 2012-08-09 Impact factor: 5.364
Authors: Alexander Jones; Merlin R McMillan; Russell W Jones; Grzegorz T Kowalik; Jennifer A Steeden; John E Deanfield; Jens C Pruessner; Andrew M Taylor; Vivek Muthurangu Journal: PLoS One Date: 2012-06-20 Impact factor: 3.240
Authors: Alexander Jones; Jens C Pruessner; Merlin R McMillan; Russell W Jones; Grzegorz T Kowalik; Jennifer A Steeden; Bryan Williams; Andrew M Taylor; Vivek Muthurangu Journal: J Physiol Date: 2016-04-28 Impact factor: 5.182
Authors: Daniel S Knight; Agata E Grasso; Michael A Quail; Vivek Muthurangu; Andrew M Taylor; Christos Toumpanakis; Martyn E Caplin; J Gerry Coghlan; Joseph Davar Journal: J Am Soc Echocardiogr Date: 2014-12-10 Impact factor: 5.251